Pacific Edge Limited

NZX:PEB.NZ

0.1 (NZD) • At close November 27, 2023
Bedrijfsnaam Pacific Edge Limited
Symbool PEB.NZ
Munteenheid NZD
Prijs 0.102
Beurswaarde 82,657,229
Dividendpercentage 0%
52-weken bereik 0.05 - 0.56
Industrie Diagnostics & Research
Sector Healthcare
CEO Dr. Peter Meintjes
Website https://www.pacificedgedx.com

An error occurred while fetching data.

Over Pacific Edge Limited

Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. It operates in two segments, Commercial and Research. The company offers Cxbladder, a genomic urine tests for the

Vergelijkbare Aandelen

Oceania Healthcare Limited logo

Oceania Healthcare Limited

OCA.NZ

0.69 NZD

Boiron SA logo

Boiron SA

BOI.PA

31.55 EUR

Uniphar plc logo

Uniphar plc

UPR.IR

2.15 EUR

GenSight Biologics S.A. logo

GenSight Biologics S.A.

SIGHT.PA

0.305 EUR

Affluent Medical SA logo

Affluent Medical SA

AFME.PA

1.765 EUR

Acticor Biotech SAS logo

Acticor Biotech SAS

ALACT.PA

0.349 EUR

GeNeuro SA logo

GeNeuro SA

GNRO.PA

0.078 EUR

Financiële Gegevens

Cijfers zijn in miljoenen (NZD)

Cijfers zijn in miljoenen (NZD)